Dr. Aleš Štrancar
Pioneer of Monolithic Chromatography and Delivery Systems Analytics. Co-founder of BIA Separations and Infinite Biotech. Inventor of CIM technology. Transforming biopharmaceutical purification for over three decades.
Advancing Biopharmaceutical Science
Dr. Aleš Štrancar is a Slovenian scientist and entrepreneur who invented CIM (Convective Interaction Media) monolithic chromatography, a technology that revolutionized the purification of large biological molecules and enabled the production of life-saving gene therapies.
Key Achievements
Co-founded BIA Separations
After starting CIM technology development in 1992, co-founded BIA Separations in 1998 to commercialize monolithic chromatography, building a world-leading bioseparation company based in Ajdovscina, Slovenia.
Invented CIM Technology
Pioneered Convective Interaction Media (CIM) monolithic chromatography, enabling the efficient purification of viruses, plasmid DNA, and gene therapy vectors at industrial scale.
Enabled Zolgensma Production
CIM technology became instrumental in the manufacturing of Zolgensma, one of the world's most expensive gene therapies for spinal muscular atrophy, developed by AveXis (Novartis).
$423M Sartorius Acquisition
In 2020, Sartorius AG acquired BIA Separations for approximately EUR 360 million ($423M), recognizing the strategic value of monolithic chromatography in gene therapy manufacturing.
Co-founded Infinite Biotech
Co-founded Infinite Biotech with the aim to develop animal-free alternatives for toxicity testing, reducing reliance on animal models in pharmaceutical development.
Learn more →Drug Delivery Systems Analytics in Nature
Co-developed analytical methods to better understand drug delivery systems, with results published in Nature, advancing the characterization of complex biopharmaceuticals.
Explore More
Discover Dr. Štrancar's scientific publications, patents, and the research areas that have shaped modern biopharmaceutical manufacturing.